BIRC5 and ovarian cancer: These results suggested that survivin expression was required for the survival and chemoresistance of ovarian cancer cells and, in turn, that domatinostat reduced the viability and increased the chemosensitivity of ovarian cancer cells through downregulation of survivin expression.